310 related articles for article (PubMed ID: 29935131)
21. Patterns and predictors of malaria care-seeking, diagnostic testing, and artemisinin-based combination therapy for children under five with fever in Northern Nigeria: a cross-sectional study.
Millar KR; McCutcheon J; Coakley EH; Brieger W; Ibrahim MA; Mohammed Z; Bassi A; Sambisa W
Malar J; 2014 Nov; 13():447. PubMed ID: 25413231
[TBL] [Abstract][Full Text] [Related]
22. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention.
Khin HS; Chen I; White C; Sudhinaraset M; McFarland W; Littrell M; Montagu D; Aung T
Malar J; 2015 Jul; 14():269. PubMed ID: 26169498
[TBL] [Abstract][Full Text] [Related]
23. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
[TBL] [Abstract][Full Text] [Related]
24. Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries.
Palafox B; Patouillard E; Tougher S; Goodman C; Hanson K; Kleinschmidt I; Torres Rueda S; Kiefer S; O'Connell K; Zinsou C; Phok S; Akulayi L; Arogundade E; Buyungo P; Mpasela F; Poyer S; Chavasse D
Health Policy Plan; 2016 Mar; 31(2):148-60. PubMed ID: 25944705
[TBL] [Abstract][Full Text] [Related]
25. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
Kaur H; Allan EL; Mamadu I; Hall Z; Ibe O; El Sherbiny M; van Wyk A; Yeung S; Swamidoss I; Green MD; Dwivedi P; Culzoni MJ; Clarke S; Schellenberg D; Fernández FM; Onwujekwe O
PLoS One; 2015; 10(5):e0125577. PubMed ID: 26018221
[TBL] [Abstract][Full Text] [Related]
26. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
[TBL] [Abstract][Full Text] [Related]
27. Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda.
Hansen KS; Pedrazzoli D; Mbonye A; Clarke S; Cundill B; Magnussen P; Yeung S
Health Policy Plan; 2013 Mar; 28(2):185-96. PubMed ID: 22589226
[TBL] [Abstract][Full Text] [Related]
28. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.
Littrell M; Gatakaa H; Phok S; Allen H; Yeung S; Chuor CM; Dysoley L; Socheat D; Spiers A; White C; Shewchuk T; Chavasse D; O'Connell KA
Malar J; 2011 Oct; 10():328. PubMed ID: 22039922
[TBL] [Abstract][Full Text] [Related]
29. Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon.
Mangham LJ; Cundill B; Achonduh OA; Ambebila JN; Lele AK; Metoh TN; Ndive SN; Ndong IC; Nguela RL; Nji AM; Orang-Ojong B; Wiseman V; Pamen-Ngako J; Mbacham WF
Trop Med Int Health; 2012 Mar; 17(3):330-42. PubMed ID: 22098135
[TBL] [Abstract][Full Text] [Related]
30. An assessment of the malaria-related knowledge and practices of Tanzania's drug retailers: exploring the impact of drug store accreditation.
Thomson R; Johanes B; Festo C; Kalolella A; Taylor M; Tougher S; Ye Y; Mann A; Ren R; Bruxvoort K; Willey B; Arnold F; Hanson K; Goodman C
BMC Health Serv Res; 2018 Mar; 18(1):169. PubMed ID: 29523139
[TBL] [Abstract][Full Text] [Related]
31. Fever case management at private health facilities and private pharmacies on the Kenyan coast: analysis of data from two rounds of client exit interviews and mystery client visits.
Poyer S; Musuva A; Njoki N; Okara R; Cutherell A; Sievers D; Lussiana C; Memusi D; Kiptui R; Ejersa W; Dolan S; Charman N
Malar J; 2018 Mar; 17(1):112. PubMed ID: 29534750
[TBL] [Abstract][Full Text] [Related]
32. Access to artemisinin combination therapy for malaria in remote areas of Cambodia.
Yeung S; Van Damme W; Socheat D; White NJ; Mills A
Malar J; 2008 May; 7():96. PubMed ID: 18510724
[TBL] [Abstract][Full Text] [Related]
33. The malaria testing and treatment landscape in Benin.
; Zinsou C; Cherifath AB
Malar J; 2017 Apr; 16(1):174. PubMed ID: 28446236
[TBL] [Abstract][Full Text] [Related]
34. Response of patent medicine vendors in rural areas of Lagos state Nigeria to antimalarial policy change.
Oyeyemi A; Ogunnowo B; Odukoya O
Afr Health Sci; 2015 Jun; 15(2):420-8. PubMed ID: 26124787
[TBL] [Abstract][Full Text] [Related]
35. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014.
Khin HS; Aung T; Thi A; White C;
Malar J; 2016 May; 15(1):286. PubMed ID: 27216408
[TBL] [Abstract][Full Text] [Related]
36. The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria.
Ikwuobe JO; Faragher BE; Alawode G; Lalloo DG
Malar J; 2013 Oct; 12():380. PubMed ID: 24172163
[TBL] [Abstract][Full Text] [Related]
37. The malaria testing and treatment landscape in mainland Tanzania, 2016.
; Michael D; Mkunde SP
Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
[TBL] [Abstract][Full Text] [Related]
38. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
39. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
[TBL] [Abstract][Full Text] [Related]
40. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
; Mpanya G; Tshefu A; Likwela JL
Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
